PTN Stock Forecast - 2022, 2025, 2030 | GlobalFinanceTrends

PTN Stock Forecast – 2022, 2023, 2024, 2025, 2030

13
PTN Stock Forecast – 2022, 2023, 2024, 2025, 2030

PTN Stock Forecast

PTN Stock Forecast 2022, 2023, 2024, 2025, 2030

Despite having made no formal news today, the PTN Stock price of Palatin Technologies Inc. (NYSEAMERICAN: PTN) rose 33.7 percent premarket. Today’s surge extended the PTN Stock rally for the third day as buyers acquired its shares.

One of the major key reasons for the current increase of PTN Stock Price might be H.C. Wainright analyst Joseph Pantginis’ recent analysis of the PTN Stock, in which he restated a buy recommendation and boosted his PTN Stock Forecast price from $2 to $5.

PTN Stock price is presently trading below $1, thus the average analyst PTN Stock Forecast price of 45 indicates significant upside.

Palatin Technologies Inc (PTN Stock) is also up 138.89 percent in the last week and has a Bullish outlook from PTN Stock Forecast 2022, 2022, 2023, 2024, 2025, 2030 experts.

PTN Stock Price Today

As of 10:00 a.m. on Monday, Nov. 29, Palatin Technologies Inc. (PTN Stock) was trading at $0.86, up $0.30, or 54.12 percent, from the last closing PTN Stock price of $0.56. Up to this point today, the PTN Stock price has ranged between $0.68 and $0.88. Today’s volume of PTN Stock is really high. So far, 21,502,882 shares have been exchanged, with an average volume of 6,441,044 shares.

Historical PTN Stock Price Data:

  • PTN Stock Market Cap (Previous Close): 184.15 M
  • PTN Stock Price in USD (Previous Close): 0.558
  • Share Volume (Previous Close): 41.37 M
  • PTN Stock Price in USD (Last): 0.796
  • 52 Week Change of Palatin Technologies Inc Stock: 0.354
  • 90-Day Moving Average of Palatin Technologies Inc Stock: 0.441
  • Beta: 1.3751107508281
  • 52 Week High Palatin Technologies Inc Stock Price: 1.3
  • 52 Week Low Palatin Technologies Inc Stock Price: 0.33
  • Palatin Technologies Inc Stock’s 50 Day Moving Average: 0.4143
  • 200 Day Moving Average of PTN Stock Price: 0.4916

14-Days Historical Palatin Technologies Inc Stock Price Data:

Date Opening Palatin Technologies Inc Stock Price Closing Palatin Technologies Inc Stock Price Minimum Palatin Technologies Inc Stock Price Maximum Palatin Technologies Inc Stock Price
2021-11-26 Open: 0.53 Close: 0.5576 Low: 0.4777 High: 0.5576
2021-11-24 Open: 0.461 Close: 0.5144 Low: 0.4419 High: 0.5586
2021-11-23 Open: 0.3579 Close: 0.3444 Low: 0.3443 High: 0.3579
2021-11-22 Open: 0.3678 Close: 0.354 Low: 0.3501 High: 0.3678
2021-11-19 Open: 0.375 Close: 0.3601 Low: 0.3601 High: 0.375
2021-11-18 Open: 0.38 Close: 0.3729 Low: 0.3722 High: 0.3888
2021-11-17 Open: 0.392 Close: 0.377 Low: 0.3755 High: 0.392
2021-11-16 Open: 0.397 Close: 0.385 Low: 0.3833 High: 0.397
2021-11-15 Open: 0.41 Close: 0.3977 Low: 0.39 High: 0.41
2021-11-12 Open: 0.4029 Close: 0.4007 Low: 0.3972 High: 0.4043
2021-11-11 Open: 0.404 Close: 0.4031 Low: 0.4 High: 0.4048
2021-11-10 Open: 0.41 Close: 0.4062 Low: 0.4051 High: 0.414
2021-11-09 Open: 0.4139 Close: 0.4105 Low: 0.4105 High: 0.4149
2021-11-08 Open: 0.4022 Close: 0.4134 Low: 0.4022 High: 0.4143

 

What Does Palatin Technologies Do?

What Does Palatin Technologies Do

In the United States, Palatin Technologies, Inc., a biopharmaceutical business, produces targeted receptor-specific medicines for the treatment of different illnesses. Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual drive disorders, is the firm’s main product. It is also working on the oral formulation of PL8177, a specific MC1r agonist peptide that has passed a Phase I medical study for the treatment of inflammatory bowel disease.

Furthermore, the business is working on PL9643, a peptide melanocortin agonist active at various MCrs, such as MC1r and MC5r, for anti-inflammatory ocular applications like dry eye illness, as well as melanocortin peptides for diabetic retinopathy. Furthermore, it is working on PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular signs, as well as PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic illnesses, along with minimizing cardiac hypertrophy and fibrosis. Palatin Technologies, Inc. was founded in 1986 and is headquartered in Cranbury, New Jersey.

Is PTN Stock a Good Buy?

According to MarketBeat statistics, Palatin Technologies Inc has an average rating of Buy. The average rating score for Palatin Stock is 3.00, based on 3 buy ratings, no hold ratings, and no sell recommendations.

Who Owns Palatin Stock?

Below, you can find the top 10 owners of Palatin Technologies Inc Stock.

Stockholder Stake PTN Stocks
owned
Total value ($) PTN Stocks
bought / sold
Total
change
The Vanguard Group, Inc. 4.07% 9,415,677 3,841,596 0 0.00%
BlackRock Fund Advisors 1.35% 3,131,704 1,277,735 +348 +0.01%
Geode Capital Management LLC 0.71% 1,651,856 673,957 0 0.00%
Acadian Asset Management LLC 0.40% 925,823 377,736 -878,716 -48.69%
Bridgeway Capital Management LLC 0.37% 864,100 352,553 -190,000 -18.02%
Winton Capital Management Ltd. 0.34% 780,370 318,391 -110,530 -12.41%
SSgA Funds Management, Inc. 0.30% 700,015 285,606 0 0.00%
Northern Trust Investments, Inc.(… 0.26% 607,991 248,060 +155,708 +34.43%
US Bancorp Asset Management, Inc. 0.07% 156,740 63,950 0 0.00%
D. E. Shaw & Co. LP 0.07% 157,665 64,327 +157,665

PTN Stock News

PTN Stock News

Focusing on the Palatin Technologies Inc’s fundamentals, we can see that it met with the US Food and Drug Administration (FDA) to discuss the phase 3 research of its dry eye medication, which is slated to begin later this quarter.

Shareholders have also drawn to the firm because it is developing a therapy for COVID-19 based on excellent preclinical data from numerous inflammatory clinical studies and a lung injury type.

The PL8177 therapy was shown to preserve lung tissue, decrease inflammation, and diminish lung fibrosis.

Palatin Technologies Inc has also benefited from market preference for equities that might gain from the newest COVID-19 strain, which enhances the urgency of finding a solution for the sickness that has caused a global epidemic and massive lockdowns.

Nevertheless, it needs to be seen whether the present rise will endure long because it has taken on a parabolic structure, which is generally followed by a large reversal.

Traders should not pursue the Palatin Technologies Inc’s PTN Stock upward since greater possibilities may arise later when the inevitable drop arrives. Yet, nothing from the markets is permanent.

Palatin Technologies Inc Stock price increased 33.68 percent to $0.7454, up from the previous day’s close of $0.5576.

PTN Stock Forecast

  • PTN Stock Forecast for the next days:
Date Palatin Technologies Inc Stock Price Min Palatin Technologies Inc Stock Price Max Palatin Technologies Inc Stock Price
2021-11-30 Price: 0.739 Min: 0.632 Max: 0.844
2021-12-01 Price: 0.777 Min: 0.672 Max: 0.879
2021-12-02 Price: 0.763 Min: 0.660 Max: 0.873
2021-12-03 Price: 0.771 Min: 0.666 Max: 0.872
2021-12-06 Price: 0.840 Min: 0.736 Max: 0.943
2021-12-07 Price: 0.769 Min: 0.668 Max: 0.871
2021-12-08 Price: 0.8070 Min: 0.7086 Max: 0.918
2021-12-09 Price: 0.794 Min: 0.679 Max: 0.90100
2021-12-10 Price: 0.8019 Min: 0.700 Max: 0.9072
2021-12-13 Price: 0.870 Min: 0.772 Max: 0.979
  • Targeted Palatin Stock Price in 14 days is 0.979 USD highest and 0.632 USD lowest.
  • 52 Week High Palatin Technologies Inc Stock Price is 376.
  • 52 Week Low Palatin Stock Price is 0.248.
  • 45-Day Moving Average of Palatin Technologies Inc Stock is 0.332.
  • 90-Day Moving Average of Palatin Technologies Inc Stock is 0.340.
  • PTN Stock Price may fall from 0.796 USD to 0.283 USD. The change of Palatin Stock Price will be -64.443%.